Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shigematsu Works CoTSE:7980 +0.37%73 ROC (Joel Greenblatt) % is 16.29% as of Mar. 2026, which is 69% above its 10-year median of 9.63. GuruFocus rates TSE:7980 with a GF Score™ of 73/100 and a GF Value™ of 円949.84 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 837 Medical Devices & Instruments companies, Shigematsu Works Co ranks better than 55.44% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Shigematsu Works Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 16.29%.
The historical rank and industry rank for Shigematsu Works Co's ROC (Joel Greenblatt) % or its related term are showing as below:
TSE:7980'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 1.74 Med: 9.63 Max: 14.12
Current: 8.69
During the past 13 years, Shigematsu Works Co's highest ROC (Joel Greenblatt) % was 14.12%. The lowest was 1.74%. And the median was 9.63%.
TSE:7980's ROC (Joel Greenblatt) % is ranked better than 55.44% of 837
companies
in the Medical Devices & Instruments industry
Industry Median: 4.35
vs TSE:7980: 8.69
Shigematsu Works Co's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -7.20% per year.
Shigematsu Works Co (TSE:7980) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Shigematsu Works Co ROC (Joel Greenblatt) % Related Terms
Shigematsu Works Co ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Shigematsu Works Co's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7980 vs ISRG, BDX, MDLN: ROC (Joel Greenblatt) % Comparison
For the Medical Instruments & Supplies subindustry, Shigematsu Works Co's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shigematsu Works Co ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shigematsu Works Co's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Shigematsu Works Co's ROC (Joel Greenblatt) % falls into.
Shigematsu Works Co ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 16.29% mean?
Shigematsu Works Co (TSE:7980) has a ROC (Joel Greenblatt) % of 16.29% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Shigematsu Works Co and its competitors. This is 69% above median its historical median of 9.63. Over the past decade, Shigematsu Works Co's ROC (Joel Greenblatt) % has ranged from 1.74 to 14.12. According to the industry distribution chart, Shigematsu Works Co ranks #373 out of 837 companies in the Medical Devices & Instruments industry, placing it in the top 44.6%.
Is Shigematsu Works Co's ROC (Joel Greenblatt) % too high?
Shigematsu Works Co's current ROC (Joel Greenblatt) % of 16.29% is 69% above median its 10-year median of 9.63. Over the past 10 years, this metric has ranged from a low of 1.74 to a high of 14.12. The Medical Devices & Instruments industry median ROC (Joel Greenblatt) % is 4.35. Shigematsu Works Co's value of 16.29% is 274.5% above this industry median. Based on the distribution chart, Shigematsu Works Co ranks #373 out of 837 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Shigematsu Works Co has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shigematsu Works Co's ROC (Joel Greenblatt) % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shigematsu Works Co ranks #373 out of 837 companies for ROC (Joel Greenblatt) %. This puts Shigematsu Works Co in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 4.35. Shigematsu Works Co's value of 16.29% is 274.5% above this benchmark. Historically, Shigematsu Works Co's own ROC (Joel Greenblatt) % has ranged from 1.74 to 14.12 over the past decade. While the company's 10-year median is 9.63 vs. the industry median of 4.35, Shigematsu Works Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 4.35, based on 837 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shigematsu Works Co's current ROC (Joel Greenblatt) % of 16.29% is 274.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Shigematsu Works Co and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 4.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shigematsu Works Co's current ROC (Joel Greenblatt) % is 16.29%, which is 69% above median its own 10-year median of 9.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shigematsu Works Co stock overvalued right now?
Based on GuruFocus' analysis, Shigematsu Works Co (TSE:7980) is currently considered Modestly Undervalued. The stock's GF Value™ is 円949.84, compared to a current price of 円815.00 — trading 14.2% below its estimated fair value. The current ROC (Joel Greenblatt) % is 16.29%, which is 69% above median its 10-year median of 9.63 and 274.5% above the Medical Devices & Instruments industry median of 4.35. Shigematsu Works Co's overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Shigematsu Works Co (TSE:7980), the current ROC (Joel Greenblatt) % is 16.29% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shigematsu Works Co (TSE:7980) Overvalued in 2026?
Based on GuruFocus' analysis, Shigematsu Works Co stock appears to be undervalued.
The current stock price of 円815.00 is trading 14.2% below its estimated GF Value™ of 円949.84.
GuruFocus considers Shigematsu Works Co to be Modestly Undervalued.
Key valuation signals for TSE:7980:
ROC (Joel Greenblatt) %: 16.29% (69% above median its 10-year median of 9.63)
GF Value™: 円949.84 vs. price of 円815.00 (14.2% below fair value)
Industry Position: 274.5% above the Medical Devices & Instruments median (#373 of 837)
No single metric tells the full story. See the TSE:7980 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shigematsu Works Co Ltd is a Japan based company engaged in the safety business. It manufactures personal and respiratory protective devices related to fire and industrial safety, equipment for air purifying, emergency and rescue operations. The company offers products such as gas respirators, chemical cartridge respirators, particulate respirators, self-contained breathing apparatus, powered air-purifying respirators, supplied-air respirators, eye protector, face shields, earmuffs, safety belts, protective clothing, protective gloves, stretchers, oxygen meters and other related products. The products offered by the organization has application in various industries including textile, chemical, automobile, fishery, mining, warehouse and others.
73GF Score
Get the complete analysis for TSE:7980
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7980 has been successfully added to your 
